1-40302811-TGGAGGGAGGGAG-TGGAGGGAGGGAGGGAG
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_001852.4(COL9A2):c.1604-6_1604-3dupCTCC variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0324 in 554,618 control chromosomes in the GnomAD database, including 185 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.029 ( 53 hom., cov: 31)
Exomes 𝑓: 0.034 ( 132 hom. )
Consequence
COL9A2
NM_001852.4 splice_region, intron
NM_001852.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.54
Genes affected
COL9A2 (HGNC:2218): (collagen type IX alpha 2 chain) This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. This chain is unusual in that, unlike the other two type IX alpha chains, it contains a covalently attached glycosaminoglycan side chain. Mutations in this gene are associated with multiple epiphyseal dysplasia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 1-40302811-T-TGGAG is Benign according to our data. Variant chr1-40302811-T-TGGAG is described in ClinVar as [Benign]. Clinvar id is 1167800.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0754 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL9A2 | ENST00000372748.8 | c.1604-3_1604-2insCTCC | splice_region_variant, intron_variant | 1 | NM_001852.4 | ENSP00000361834.3 | ||||
COL9A2 | ENST00000482722.5 | n.1907-3_1907-2insCTCC | splice_region_variant, intron_variant | 1 | ||||||
COL9A2 | ENST00000427563.1 | n.360-3_360-2insCTCC | splice_region_variant, intron_variant | 3 | ||||||
COL9A2 | ENST00000466267.1 | n.569-3_569-2insCTCC | splice_region_variant, intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0287 AC: 3614AN: 125770Hom.: 53 Cov.: 31
GnomAD3 genomes
AF:
AC:
3614
AN:
125770
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0298 AC: 4095AN: 137322Hom.: 42 AF XY: 0.0294 AC XY: 2185AN XY: 74414
GnomAD3 exomes
AF:
AC:
4095
AN:
137322
Hom.:
AF XY:
AC XY:
2185
AN XY:
74414
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0335 AC: 14374AN: 428750Hom.: 132 Cov.: 36 AF XY: 0.0343 AC XY: 7932AN XY: 231318
GnomAD4 exome
AF:
AC:
14374
AN:
428750
Hom.:
Cov.:
36
AF XY:
AC XY:
7932
AN XY:
231318
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0287 AC: 3617AN: 125868Hom.: 53 Cov.: 31 AF XY: 0.0292 AC XY: 1744AN XY: 59798
GnomAD4 genome
AF:
AC:
3617
AN:
125868
Hom.:
Cov.:
31
AF XY:
AC XY:
1744
AN XY:
59798
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 25, 2016 | - - |
not specified Benign:2
Benign, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Epiphyseal dysplasia, multiple, 2;C3280342:Stickler syndrome, type 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 14, 2021 | - - |
Connective tissue disorder Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Feb 12, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at